Tesamorelin vs CJC-1295 (No DAC) UAE: Pulse vs Sustained GHRH, Dose Schedule, and the Buyer's Edge in Dubai

If you searched tesamorelin vs CJC-1295 no DAC UAE, you are almost certainly choosing between two GHRH analogs for a research protocol — and you want to know which one is worth ordering in Dubai today. At REVIVE LAB UAE we get this question weekly from labs in Business Bay, Dubai Marina, JBR, Jumeirah, DIFC, Abu Dhabi, Sharjah and Al Ain. Short version: if you want pulsatile GH with the strongest published evidence — especially for visceral adipose tissue (VAT) endpoints — tesamorelin wins on data. CJC-1295 (no DAC) is a faster, shorter pulse with less peer-reviewed muscle behind it. Below is the head-to-head, with dose schedules, half-life math, and buyer notes for UAE researchers ordering peptides Dubai-wide.

The Core Difference: Pulse vs Sustained GHRH Signaling

Both molecules are growth hormone releasing hormone (GHRH) analogs — they bind the GHRH receptor on pituitary somatotrophs and trigger endogenous GH release. The pharmacokinetic profiles, however, are not the same animal:

• Tesamorelin — a stabilized GHRH(1-44) analog with a trans-3-hexenoic acid modification at the N-terminus. Plasma half-life ~26 minutes after subcutaneous injection, but downstream IGF-1 elevation persists 24+ hours. Produces a clean, physiologic GHRH pulse without flattening the natural nocturnal GH rhythm (Stanley 2014; Falutz 2007).
• CJC-1295 (no DAC) — also called Mod GRF (1-29). A truncated GHRH(1-29) with four amino acid substitutions for protease resistance. Half-life ~30 minutes. Designed for short, sharp pulses — typically stacked with a GHRP (ipamorelin, GHRP-2) to amplify the burst. Without DAC (drug-affinity complex), it does NOT bind albumin and therefore does NOT have the 6-8 day half-life of CJC-1295-DAC.

In research terms: tesamorelin gives you one daily pulse with a clinically-proven downstream IGF-1 signature. CJC-1295 no DAC gives you a quick spike that researchers usually stack 2-3x/day with a GHRP. Different tools, different jobs.

Side-by-Side Comparison Table

Why the Stanley 2014 Trial Tilts the Field

The single biggest reason researchers across the UAE — from Emirates Hills to Yas Island — keep ordering tesamorelin is the Stanley 2014 lipodystrophy dataset. That 26-week randomized controlled trial showed tesamorelin 2 mg/day produced an ~18% reduction in visceral adipose tissue versus placebo, with preserved subcutaneous fat and lean mass. The Falutz 2007 and 2010 NEJM follow-ups confirmed the IGF-1 elevation was dose-proportional and the GH pulsatility remained physiologic — no flat-line, no receptor desensitization at standard dosing.

CJC-1295 without DAC has no comparable controlled human trial. The original Teichman 2006 paper studied CJC-1295-DAC (the long-acting albumin-bound version, which is a different molecule and a different risk profile). For "no DAC" / Mod GRF (1-29), the published evidence is essentially pilot pharmacokinetics — useful, but not the same weight class.

Dose Schedule Math: Why Tesamorelin Is Simpler

Here is the practical reason most UAE researchers we ship to in JVC, Mirdif, Al Barsha, Dubai Hills, MBR City and Arabian Ranches consolidate on tesamorelin: dose schedule simplicity.

Tesamorelin protocol (research-use)

• Reconstitute one 5 mg vial with 3 mL BAC water (bacteriostatic water) → 1.67 mg/mL.
• Standard research dose: 2 mg SC once daily, evening, abdomen rotation.
• One vial ≈ 2.5 days at full dose, or 5 days at 1 mg titration.
• 1 mL insulin syringe, 29G or 31G needle, fridge storage post-reconstitution.
• One pulse per 24h, no stacking math, no timing gymnastics.

CJC-1295 no DAC protocol (research-use, for reference)

• Reconstitute with BAC water, typical 100 mcg dose 1-3x daily.
• Almost always paired with ipamorelin 100-200 mcg to get a meaningful GH pulse.
• Requires careful pre-bed timing to avoid blunting natural GH rhythm.
• Three injections per day = three timing windows = three opportunities to break protocol fidelity.

For most UAE labs, the one-pulse-per-day tesamorelin model is easier to keep clean across a 12-week or 26-week study window. That alone is a reason many researchers across Dubai and Abu Dhabi switch.

Same-Day Delivery Across UAE — How to Order from REVIVE LAB UAE

REVIVE LAB UAE is the UAE-based peptides supplier built specifically for researchers in this region. We hold tesamorelin 5 mg and 10 mg vials in temperature-controlled inventory and ship cold-chain courier with discreet, anonymous packaging.

• Dubai same-day: Dubai Marina, JBR, Jumeirah Beach Residence, Business Bay, Downtown Dubai, Palm Jumeirah, DIFC, JVC, Jumeirah Village Circle, Emirates Hills, Arabian Ranches, Mirdif, Al Barsha, Dubai Hills, MBR City.
• 24h cold-chain courier: Abu Dhabi, Yas Island, Al Reem Island, Khalifa City, Al Ain, Sharjah, Ajman, Ras Al Khaimah (RAK), Fujairah, Umm Al Quwain.
• Payment: tesamorelin cash on delivery UAE (COD Dubai) accepted, plus card.
• Packaging: tesamorelin discreet packaging UAE — plain outer, ice-pack inner, no peptide labeling externally.

Why REVIVE LAB UAE for Peptides Dubai-Wide

REVIVE Peptides UAE is a UAE-based research peptides supplier serving labs and researchers across all seven emirates. Every batch of tesamorelin we sell ships with an HPLC certificate of analysis verifying purity, vial integrity is checked at dispatch, and orders move on cold-chain courier the same day from our Dubai facility. We stock the working strengths researchers actually use — tesamorelin 5 mg and 10 mg vials — alongside the full REVIVE Peptides UAE catalog: Retatrutide 5/10 mg, GHK-Cu 50/100 mg, BPC-157 5 mg, TB-500 5 mg, MOTS-c 10 mg, Semax 10 mg, NAD+ 100 mg, and BAC water 3 mL. Browse all REVIVE Peptides UAE products or jump straight to the tesamorelin money page below.

FAQ — Tesamorelin vs CJC-1295 No DAC for UAE Researchers

Where can I buy tesamorelin in the UAE with same-day delivery?

REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials with same-day dispatch across Dubai (Marina, JBR, Business Bay, Downtown, Palm Jumeirah, JVC, Mirdif, Al Barsha) and 24h cold-chain courier to Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain and Al Ain. Order direct at revivelab.ae — tesamorelin in stock UAE, cash on delivery accepted.

Is tesamorelin better than CJC-1295 (no DAC) for visceral fat research?

For visceral adipose tissue endpoints, yes — tesamorelin is the only GHRH analog with phase III RCT data showing ~18% VAT reduction over 26 weeks (Stanley 2014). CJC-1295 no DAC has not been demonstrated to reduce VAT in controlled trials.

What's the typical research dose schedule for each?

Tesamorelin: 2 mg SC once daily (Falutz 2007, Stanley 2014). CJC-1295 no DAC: 100 mcg SC 1-3x daily, usually stacked with a GHRP. Tesamorelin's once-daily schedule is significantly simpler for long-window protocols.